Jimmy Caudell
Create your FREE profile now!

Join the discussion with physicians and researchers around the globe - sign up for your free Cureus account today.


Dr. Caudell joined the Moffitt Faculty in October 2011 as Assistant Member in the Head and Neck program, Radiation Oncology specializing in the treatment of head and neck cancers. Dr. Caudell’s clinical interests include treatment of head and neck cancer and cutaneous malignancies with radioth­­­erapy. Research interests include prediction of radiation sensitivity, evaluation of novel radiosensitizers and radioprotectants, as well as the use of technology to improve radiation delivery for head and neck cancer. Dr. Caudell is currently co-PI on the national NRG HN-002 prospective clinical trial testing methods to reduce toxicity for patients with low risk oropharyngeal HPV positive H&N cancer. In addition, Dr. Caudell is PI on a phase I dose escalation trial of H&N SBRT with concurrent chemotherapy for patients with recurrent, unresectable H&N cancer. He is also PI of a grant to predict the benefit of post-operative radiotherapy in H&N cancer using a gene expression signature of tumor radiosensitivity. Dr. Caudell continues his research through retrospective analysis of patients treated for H&N malignancies (primary and metastatic).

Dr. Caudell’s research has focused primarily on treatment outcomes with respect to both cancer control and toxicity. From a clinical standpoint, his work on treatment planning and dysphagia following radiation treatment has been nationally recognized. He also has performed research in treatment disparities and novel radiation delivery techniques for head and neck cancer. Dr. Caudell’s role in many collaborative projects is to provide clinical expertise regarding the outcomes and toxicities associated with radiation treatment for H&N cancers. While at Moffitt Dr. Caudell has been instrumental in development of the H&N/Endocrine Clinical Pathways, serves on the MMG Revenue Cycle Committee and Center of Excellence in Cancer Imaging and Technology, and has been a member of Moffitt’s Scientific Symposium Committee.

As an educator, Dr. Caudell works closely with the Radiation Oncology Residency Clinical Competency Committee and provides consistent mentorship to our Radiation Oncology Residents through clinic rotations and lectures. Lecture topics for the Department of Otolaryngology of the University of South Florida and Moffitt H&N Symposium include “Chemoradiation of the Head and Neck” and “Current Management of Locally Advanced HPV-Negative Head & Neck Cancer.” Dr. Caudell currently serves as H&N Service Chief and has added the H&N SBRT Program. Outside of Moffitt Dr. Caudell is a member of the RTOG/NRG H&N Steering Committee, RTOG 1016 QA Committee, National Comprehensive Cancer Network (NCCN) H&N Panel and H&N Radiation Oncology Sub-Committee.